TWi Pharmaceuticals Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Private

  • Employees
  • 215

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

  • Investments
  • 4

TWi Pharmaceuticals General Information

Description

Manufacturer of generic drugs intended to specialize development and commercialization of niche generic drugs. The company is engaged in the research and development, contract manufacturing and contract research including advanced scientific research, process development, patent analysis, regulatory compliance, and market and competition analysis, enabling its customers to avail the drug for combating disease and leading a healthier life.

Contact Information

Formerly Known As
Empax Pharma
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 3F, Number 41, Lane 221
  • Gangqian Road
  • Taipei City, Nei Hu 114
  • Taiwan
+886 02
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 3F, Number 41, Lane 221
  • Gangqian Road
  • Taipei City, Nei Hu 114
  • Taiwan
+886 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TWi Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore TWi Pharmaceuticals‘s full profile, request access.

Request a free trial

TWi Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of generic drugs intended to specialize development and commercialization of niche generic drugs. The compa
Drug Discovery
Taipei City, Taiwan
215 As of 2014

Saint Laurent, Canada
 

Karachi, Pakistan
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TWi Pharmaceuticals Competitors (34)

One of TWi Pharmaceuticals’s 34 competitors is Nymox Pharmaceutical, a Corporation company based in Saint Laurent, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nymox Pharmaceutical Corporation Saint Laurent, Canada
Hoechst Pakistan Corporate Backed or Acquired Karachi, Pakistan
Cipla Corporation Mumbai, India
Genzyme Ireland Corporation Kilmeaden, Ireland
Chiesi Farmaceutici Private Debt Financed Parma, Italy
You’re viewing 5 of 34 competitors. Get the full list »

TWi Pharmaceuticals Patents

TWi Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2021512096-A Topical formulation containing tofacitinib Active 31-Jan-2018
US-12161748-B2 Topical formulations comprising tofacitinib Active 31-Jan-2018
US-20210212931-A1 Topical formulations comprising tofacitinib Active 31-Jan-2018
WO-2019152232-A1 Topical formulations comprising tofacitinib Inactive 31-Jan-2018
US-20150209292-A1 Controlled release formulations and preparation method thereof Inactive 27-Jan-2014 A61K31/4458
To view TWi Pharmaceuticals’s complete patent history, request access »

TWi Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TWi Pharmaceuticals Investments & Acquisitions (4)

TWi Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with Sevelamer ANDA. The deal was made on 01-Oct-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sevelamer ANDA 01-Oct-2018 Corporate Asset Purchase Buildings and Property
Visum Pharmaceutical 01-Jan-2015 Corporate Drug Discovery
Visum Pharmaceutical 26-Sep-2014 Merger/Acquisition Drug Discovery
Visum Pharmaceutical 10-Apr-2014 Secondary Transaction - Private Drug Discovery
To view TWi Pharmaceuticals’s complete investments and acquisitions history, request access »

TWi Pharmaceuticals Exits (3)

TWi Pharmaceuticals’s most recent exit was on 01-Jan-2015 from Visum Pharmaceutical. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Visum Pharmaceutical 01-Jan-2015 Completed
Visum Pharmaceutical 26-Sep-2014 Completed
Visum Pharmaceutical 10-Apr-2014 Secondary Transaction - Private Completed
To view TWi Pharmaceuticals’s complete exits history, request access »

TWi Pharmaceuticals FAQs

  • When was TWi Pharmaceuticals founded?

    TWi Pharmaceuticals was founded in 2002.

  • Where is TWi Pharmaceuticals headquartered?

    TWi Pharmaceuticals is headquartered in Taipei City, Taiwan.

  • What is the size of TWi Pharmaceuticals?

    TWi Pharmaceuticals has 215 total employees.

  • What industry is TWi Pharmaceuticals in?

    TWi Pharmaceuticals’s primary industry is Drug Discovery.

  • Is TWi Pharmaceuticals a private or public company?

    TWi Pharmaceuticals is a Private company.

  • What is TWi Pharmaceuticals’s current revenue?

    The current revenue for TWi Pharmaceuticals is .

  • How much funding has TWi Pharmaceuticals raised over time?

    TWi Pharmaceuticals has raised $111M.

  • Who are TWi Pharmaceuticals’s competitors?

    Nymox Pharmaceutical, Hoechst Pakistan, Cipla, Genzyme Ireland, and Chiesi Farmaceutici are some of the 34 competitors of TWi Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process